Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I and II Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Therapeutic targeting of orphan NR in ER-negative breast cancer
Molecular and biochemical basis of Lymphangioleiomyomatosis
Molecular genetics and population studies of the KIR and HLA gene complexes
Protein Knockout Technology/Molecular Analysis of Cancer
Transition to Research Careers
Recently added grants:
Implementing mHealth for Schizophrenia in Community Mental Health Settings
Investigating Social Competence in Youth with Autism: A Multisite RCT
Innovation of methods for in vivo monitoring and manipulation of neurotensin circuits
Randomized trial of telehealth group intervention to reduce perinatal depressive symptoms in diverse populations
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35160-8-0-1
Application #
7579646
Study Section
Project Start
2003-09-30
Project End
2009-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase I and II Clinical Trials of Agents for Cancer Prevention
/ University of California Irvine
$750,000
NIH 2007
N01 CA
Phase I and II Clinical Trials of Cancer Chemopreventive Agents
Meyskens, Frank Louis /
$1,577,000
NIH 2007
N01 CA
Phase I and II Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant